Fortress Biotech Inc. (NASDAQ: FBIO) Starts Presentation at 12th Annual LD Micro Main Event
Fortress Biotech (NASDAQ: FBIO) is an innovative biopharmaceutical company focused on identifying, in-licensing, and developing high-potential clinical-stage assets. The company has over 25 programs in clinical development at Fortress, at its majority-owned and majority-controlled subsidiaries, and at entities it founded and in which it holds significant minority ownership positions. Such product candidates span six large-market therapeutic areas, including oncology, rare diseases and gene therapy, which allow it to create value while mitigating risk for shareholders. Fortress advances its diversified pipeline through a streamlined operating structure that fosters efficient drug development. For more information, visit the company’s website at www.fortressbiotech.com. About…
